Derived from a young human female, the NCI-H292 cell line
comes from the mucoepidermoid pulmonary carcinoma of a metastasized lung cancer
found in the lymph node. The cell line has been used for viral research and
related drug development tied to infection by the herpes simplex, mumps, and
measles viruses. With an epithelial morphology, NCI-H292 cells are easy to grow
in culture and modify genetically using optimized transfection
reagents. Therapies relying on gene-silencing via siRNA transfection or the
introduction of important protein sequences into cells can be tested quickly
and efficiently in the cell line, granting quick and reliable results.
The NCI-H292 cell line was established from the lymph node metastasis lung tissue of a 32-year-old female patient with mucoepidermoid pulmonary carcinoma. NCI-H292 cells are tumorigenic cells that display an epithelial morphology and adherent cultural properties, able to retain their mucoepidermoid characteristics. NCI-H292 produces keratin and vimentin, and is also susceptible to Hepatitis B virus. NCI-H292 cells are suitable transfection hosts to study lung cancer and Altogen Biosystems offers an optimized NCI-H292 reagent to transfect NCI-H292 cells.
Comments
Post a Comment